AnalystsAndrew BerensAndrew Berens's Stock Forecasts
AnalystsAndrew Berens
Analyst Ranking
Bottom 1%
#3503 out of 3525 analysts
Average Return
-11.39%
Win Rate
33%25 out of 75
Risk vs Reward
Poor
Good
Andrew Berens's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Blueprint Medicines CorpBPMC | +130.14% | $35.87 | $82.55 | 2017-02-14 - 2018-02-15 | Strong Buy |
Zentalis Pharmaceuticals IncZNTL | +67.39% | $35.57 | $59.54 | 2020-04-27 - 2021-04-28 | Buy |
Blueprint Medicines CorpBPMC | +64.43% | $60.13 | $98.87 | 2020-04-28 - 2021-04-29 | Buy |
Zentalis Pharmaceuticals IncZNTL | +60.78% | $45.66 | $73.41 | 2021-04-12 - 2021-12-01 | Buy |
Agios Pharmaceuticals IncAGIO | +40.36% | $33.80 | $47.44 | 2020-12-08 - 2021-02-26 | Buy |
Andrew Berens's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aura Biosciences IncAURA | 1 | Buy | $40.00 | +120.87% | Initiates Coverage On | 10 days ago |
Agios Pharmaceuticals IncAGIO | 4 | Hold | $42.00 | +19.86% | Maintains | 14 days ago |
Forma Therapeutics Holdings IncFMTX | 4 | Buy | $40.00 | +194.12% | Maintains | 20 days ago |
HOOKIPA Pharma IncHOOK | 1 | Buy | $10.00 | +224.68% | Maintains | 22 days ago |
Zymeworks IncZYME | 5 | Hold | $27.00 | +33.40% | Maintains | 23 days ago |
Theseus Pharmaceuticals IncTHRX | 1 | Buy | $28.00 | +83.13% | Initiates Coverage On | a month ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $64.00 | +125.27% | Maintains | a month ago |
Seagen IncSGEN | 13 | Buy | $200.00 | +26.38% | Maintains | a month ago |
Arvinas IncARVN | 1 | Buy | $115.00 | +51.66% | Initiates Coverage On | 2 months ago |
C4 Therapeutics IncCCCC | 1 | Buy | $67.00 | +94.82% | Initiates Coverage On | 2 months ago |
Monte Rosa Therapeutics IncGLUE | 1 | Hold | $20.00 | +14.88% | Initiates Coverage On | 2 months ago |
BeiGene LtdBGNE | 3 | Buy | $414.00 | +17.62% | Maintains | 2 months ago |
Merus NVMRUS | 2 | Buy | $45.00 | +79.64% | Maintains | 2 months ago |
Astrazeneca PlcAZN | 6 | Buy | $73.00 | +33.02% | Maintains | 2 months ago |
Incyte CorpINCY | 6 | Hold | $66.00 | +1.60% | Upgrades | 2 months ago |
Mirati Therapeutics IncMRTX | 2 | Buy | $205.00 | +55.26% | Maintains | 2 months ago |
Tango Therapeutics IncTNGX | 1 | Buy | $25.00 | +150.00% | Initiates Coverage On | 2 months ago |
Elevation Oncology IncELEV | 1 | Buy | $20.00 | +168.46% | Initiates Coverage On | 4 months ago |
Blueprint Medicines CorpBPMC | 7 | Buy | $137.00 | +42.66% | Maintains | 6 months ago |
Cullinan Oncology IncCGEM | 2 | Buy | $54.00 | +226.09% | Maintains | 6 months ago |
Epizyme IncEPZM | 4 | Buy | $16.00 | +447.01% | Upgrades | 7 months ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $18.00 | +337.96% | Initiates Coverage On | 7 months ago |
Global Blood Therapeutics IncGBT | 1 | Buy | $54.00 | +99.04% | Initiates Coverage On | 8 months ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Buy | $64.00 | -12.82% | Maintains | 8 months ago |
Aveo Pharmaceuticals IncAVEO | 2 | Buy | $18.00 | +204.05% | Maintains | 9 months ago |
Deciphera Pharmaceuticals IncDCPH | 3 | Buy | $70.00 | +775.00% | Upgrades | 10 months ago |
Cogent Biosciences IncCOGT | 1 | Buy | $20.00 | +166.31% | Initiates Coverage On | a year ago |
Turning Point Therapeutics IncTPTX | 3 | Buy | $127.00 | +248.23% | Maintains | a year ago |
Clovis Oncology IncCLVS | 2 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
Nabriva Therapeutics plcNBRV | 2 | Strong Buy | $8.00 | N/A | Reinstates | 3 years ago |
TESARO IncTSRO | 2 | Strong Buy | $146.00 | N/A | Maintains | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $50.00 | N/A | Maintains | 4 years ago |
Ocular Therapeutix IncOCUL | 2 | Hold | $8.00 | N/A | Maintains | 4 years ago |
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.